The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is ...

Press Release - A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024.

The newly prequalified vaccine, TAK-003 is developed by a multinational pharmaceutical company, Takeda as the second dengue ...

The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF. Photo: AFP A new ...

The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda ...

The World Health Organization (WHO) said it had prequalified the second dengue vaccine, TAK-003 as a new weapon in the fight ...

The World Health Organization (WHO) has granted prequalification to a new dengue vaccine, TAK-003, on 10th of May this year.

The World Health Organization (WHO) today announced that it has prequalified a second dengue vaccine, TAK-003, known as Qdenga and developed by Takeda. Monica R/ Flickr cc Qdenga is a live-attenuated ...

The WHO has prequalified a second dengue vaccine called TAK-003 The TAK-003 vaccine has been made by the Japanese drug maker Takeda Pharmaceuticals TAK-003 can be administered to children aged 6 to 16 ...

On May 10, 2024, the World Health Organization (WHO) prequalified a new vaccine for dengue, a significant move in the fight against the mosquito-borne disease. The vaccine, known as TAK-003, is the ...